share_log

4: Statement of changes in beneficial ownership of securities-Director McMullen Michael R.

SEC ·  Oct 3 05:44

Summary by Futu AI

Michael R. McMullen, associated with Bristol-Myers Squibb (BMY), has engaged in a transaction involving the company's stock on September 30, 2024. Specific details regarding the nature of the transaction, including the number of shares traded, the transaction price, and the resulting shareholding, were not disclosed in the announcement.
Michael R. McMullen, associated with Bristol-Myers Squibb (BMY), has engaged in a transaction involving the company's stock on September 30, 2024. Specific details regarding the nature of the transaction, including the number of shares traded, the transaction price, and the resulting shareholding, were not disclosed in the announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated